Winter 2020/2021 Vol. 10 Issue 04
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
New Rules of EngagementAs the pandemic continues, cancer patients and survivors must weight fears of possible infection with their need to live fully.
by Hester Hill Schnipper
-
Caregiving With Confidence
Anticipatory GriefWhen a loved one has advanced cancer, it's common to mourn the loss that hasn't happened yet.
by Karen J. Bannan
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
-
Are Liquid Biopsies Ready for the Clinic?
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
-
Getting Serious About Depression
Cancer survivors have higher rates of depression than the general population, but many don't know help is available.
by Cameron Walker
-
Multiple Myeloma: Choosing Your Path
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
-
Survivor Profile
A Voice at RiskRob Paulsen has voiced hundreds of animated characters, but as he prepared to return to a beloved role, cancer threatened his livelihood.
by Bradley Jones
-
Q&A
Ethics in PracticeRebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersExperts answer questions about limiting exposure to the coronavirus, how to talk about a cancer recurrence with loved ones, and strategies for dealing with a loss of health insurance.
-
Get Involved
Smiling FacesRich Nardiello seeks to bring a smile to children with cancer.
by Bradley Jones
-
Facts and Stats
2020: Cancer in the U.S.Data collected from cancer registries help chart the national burden of cancer.
by Bradley Jones
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
